Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lambda therapeutics limited - kvetiapin - tableta s podaljšanim sproščanjem - kvetiapin 300 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lambda therapeutics limited - kvetiapin - tableta s podaljšanim sproščanjem - kvetiapin 400 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lambda therapeutics limited - kvetiapin - tableta s podaljšanim sproščanjem - kvetiapin 200 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lambda therapeutics limited - kvetiapin - tableta s podaljšanim sproščanjem - kvetiapin 300 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lambda therapeutics limited - kvetiapin - tableta s podaljšanim sproščanjem - kvetiapin 200 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lambda therapeutics limited - kvetiapin - tableta s podaljšanim sproščanjem - kvetiapin 400 mg / 1 tableta - kvetiapin

Evropska unija - slovenščina - EMA (European Medicines Agency)

merck sharp dohme ltd - boceprevir - hepatitis c, kronični - antivirusi za sistemsko uporabo - victrelis je indicirano za zdravljenje kroničnega hepatitisa c (chc) genotip 1 okužbe, v kombinaciji z peginterferon alfa in ribavirin pri odraslih bolnikih z nadomestiti bolezen jeter, ki so predhodno nezdravljenih ali ki niso prejšnje zdravljenje.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international nv - guselkumab - psoriaza - imunosupresivi - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.

Evropska unija - slovenščina - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.